Feedback / Questions
prexasertib (ACR-368) - Acrivon Therap
ACR-368: Protection of composition-of-matter patent until Oct 2030
(Acrivon Therapeutics)
-
Oct 30, 2025 -
Corporate Presentation: Protection of patent related to salt form until Apr 2037
Patent
•
Oncology
https://ir.acrivon.com/static-files/57832e89-c921-41c7-8441-81d21b206413
Oct 30, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious